Author Correction: High-throughput single-cell activity-based screening and sequencing of antibodies using droplet microfluidics

Annabelle Gérard¹, Adam Woolfe^#¹, Guillaume Mottet^#², Marcel Reichen^#¹, Carlos Castrillon^#^{2

3

4}, Vera Menrath^#¹, Sami Ellouze^#¹, Adeline Poitou^#¹, Raphaël Doineau^#^{1

3

4

5}, Luis Briseno-Roa^{1

6}, Pablo Canales-Herrerias^{2

3

7}, Pascaline Mary⁸, Gregory Rose⁸, Charina Ortega⁸, Matthieu Delincé⁸, Sosthene Essono⁸, Bin Jia^{9

10}, Bruno Iannascoli², Odile Richard-Le Goff², Roshan Kumar⁸, Samantha N Stewart⁸, Yannick Pousse¹, Bingqing Shen¹, Kevin Grosselin^{1

4}, Baptiste Saudemont^{2

4}, Antoine Sautel-Caillé⁴, Alexei Godina⁴, Scott McNamara¹, Klaus Eyer^{7

11}, Gaël A Millot¹², Jean Baudry⁷, Patrick England^{13

14}, Clément Nizak⁴, Allan Jensen^{1

15}, Andrew D Griffiths¹⁶, Pierre Bruhns¹⁷, Colin Brenan^{18

19

20}

Affiliations

¹ HiFiBiO Therapeutics SAS, Paris, France.
² Unit of Antibodies in Therapy and Pathology, Institut Pasteur, UMR1222 INSERM, Paris, France.
³ École Doctorale Frontières du Vivant (FdV), Centre de Recherches Interdisciplinaires, Paris, France.
⁴ Laboratoire de Biochimie (LBC), ESPCI Paris, PSL Research University, CNRS UMR8231 Chimie Biologie Innovation, Paris, France.
⁵ Institute for Integrative Nanosciences, Leibniz IFW Dresden e.V., Dresden, Germany.
⁶ Medetia Pharma, Institut Imagine, Paris, France.
⁷ Laboratoire Colloïdes et Matériaux Divisés (LCMD), ESPCI Paris, PSL Research University, CNRS UMR8231 Chimie Biologie Innovation, Paris, France.
⁸ HiFiBiO Therapeutics Inc., Cambridge, MA, USA.
⁹ Pfizer, Cambridge, MA, USA.
¹⁰ Abbvie Bioresearch Center, Worcester, MA, USA.
¹¹ Laboratory for Functional Immune Repertoire Analysis, Institute of Pharmaceutical Sciences, D-CHAB, ETH Zürich, Zurich, Switzerland.
¹² Institut Pasteur, Hub Bioinformatique et Biostatistique, C3BI, USR 3756 IP CNRS, Paris, France.
¹³ Plateforme de Biophysique Moléculaire, Institut Pasteur, CNRS UMR3528, Paris, France.
¹⁴ Centre d'Innovation et de Technologie, Plateforme de Biophysique des Macromolecules et de leurs Interactions, Institut Pasteur, Paris, France.
¹⁵ Lundbeck A/S, Valby, Denmark.
¹⁶ Laboratoire de Biochimie (LBC), ESPCI Paris, PSL Research University, CNRS UMR8231 Chimie Biologie Innovation, Paris, France. andrew.griffiths@espci.fr.
¹⁷ Unit of Antibodies in Therapy and Pathology, Institut Pasteur, UMR1222 INSERM, Paris, France. pierre.bruhns@pasteur.fr.
¹⁸ HiFiBiO Therapeutics SAS, Paris, France. c.brenan@1cell-bio.com.
¹⁹ HiFiBiO Therapeutics Inc., Cambridge, MA, USA. c.brenan@1cell-bio.com.
²⁰ 1CellBiO Inc., Watertown, MA, USA. c.brenan@1cell-bio.com.

^# Contributed equally.

PMID: 32444853
DOI: 10.1038/s41587-020-0563-7

Published Erratum

Author Correction: High-throughput single-cell activity-based screening and sequencing of antibodies using droplet microfluidics

Annabelle Gérard et al. Nat Biotechnol. 2020 Jun.

. 2020 Jun;38(6):756.

doi: 10.1038/s41587-020-0563-7.

Authors

Affiliations

¹ HiFiBiO Therapeutics SAS, Paris, France.
² Unit of Antibodies in Therapy and Pathology, Institut Pasteur, UMR1222 INSERM, Paris, France.
³ École Doctorale Frontières du Vivant (FdV), Centre de Recherches Interdisciplinaires, Paris, France.
⁴ Laboratoire de Biochimie (LBC), ESPCI Paris, PSL Research University, CNRS UMR8231 Chimie Biologie Innovation, Paris, France.
⁵ Institute for Integrative Nanosciences, Leibniz IFW Dresden e.V., Dresden, Germany.
⁶ Medetia Pharma, Institut Imagine, Paris, France.
⁷ Laboratoire Colloïdes et Matériaux Divisés (LCMD), ESPCI Paris, PSL Research University, CNRS UMR8231 Chimie Biologie Innovation, Paris, France.
⁸ HiFiBiO Therapeutics Inc., Cambridge, MA, USA.
⁹ Pfizer, Cambridge, MA, USA.
¹⁰ Abbvie Bioresearch Center, Worcester, MA, USA.
¹¹ Laboratory for Functional Immune Repertoire Analysis, Institute of Pharmaceutical Sciences, D-CHAB, ETH Zürich, Zurich, Switzerland.
¹² Institut Pasteur, Hub Bioinformatique et Biostatistique, C3BI, USR 3756 IP CNRS, Paris, France.
¹³ Plateforme de Biophysique Moléculaire, Institut Pasteur, CNRS UMR3528, Paris, France.
¹⁴ Centre d'Innovation et de Technologie, Plateforme de Biophysique des Macromolecules et de leurs Interactions, Institut Pasteur, Paris, France.
¹⁵ Lundbeck A/S, Valby, Denmark.
¹⁶ Laboratoire de Biochimie (LBC), ESPCI Paris, PSL Research University, CNRS UMR8231 Chimie Biologie Innovation, Paris, France. andrew.griffiths@espci.fr.
¹⁷ Unit of Antibodies in Therapy and Pathology, Institut Pasteur, UMR1222 INSERM, Paris, France. pierre.bruhns@pasteur.fr.
¹⁸ HiFiBiO Therapeutics SAS, Paris, France. c.brenan@1cell-bio.com.
¹⁹ HiFiBiO Therapeutics Inc., Cambridge, MA, USA. c.brenan@1cell-bio.com.
²⁰ 1CellBiO Inc., Watertown, MA, USA. c.brenan@1cell-bio.com.

^# Contributed equally.

PMID: 32444853
DOI: 10.1038/s41587-020-0563-7

Abstract

An amendment to this paper has been published and can be accessed via a link at the top of the paper.

PubMed Disclaimer

Erratum for

High-throughput single-cell activity-based screening and sequencing of antibodies using droplet microfluidics.
Gérard A, Woolfe A, Mottet G, Reichen M, Castrillon C, Menrath V, Ellouze S, Poitou A, Doineau R, Briseno-Roa L, Canales-Herrerias P, Mary P, Rose G, Ortega C, Delincé M, Essono S, Jia B, Iannascoli B, Richard-Le Goff O, Kumar R, Stewart SN, Pousse Y, Shen B, Grosselin K, Saudemont B, Sautel-Caillé A, Godina A, McNamara S, Eyer K, Millot GA, Baudry J, England P, Nizak C, Jensen A, Griffiths AD, Bruhns P, Brenan C. Gérard A, et al. Nat Biotechnol. 2020 Jun;38(6):715-721. doi: 10.1038/s41587-020-0466-7. Epub 2020 Mar 30. Nat Biotechnol. 2020. PMID: 32231335

Publication types

Actions

LinkOut - more resources

Full Text Sources
- Nature Publishing Group

Save citation to file

Email citation

Add to Collections

Add to My Bibliography

Your saved search

Create a file for external citation management software

Your RSS Feed

Author Correction: High-throughput single-cell activity-based screening and sequencing of antibodies using droplet microfluidics

Affiliations

Author Correction: High-throughput single-cell activity-based screening and sequencing of antibodies using droplet microfluidics

Authors

Affiliations

Abstract

Erratum for

Publication types

LinkOut - more resources

Full Text Sources